Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.8.0.1
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Basic and diluted numerator:        
Net loss attributable to iBio, Inc. $ (3,899) $ (3,229) $ (7,725) $ (6,290)
Preferred stock dividends 65 0 131 0
Net loss available to iBio, Inc. stockholders $ (3,964) $ (3,229) $ (7,856) $ (6,290)
Basic and diluted denominator:        
Weighted-average common shares outstanding 96,609 89,109 96,127 89,109
Per share amount $ (0.04) $ (0.04) $ (0.08) $ (0.07)